Venezuela makes up less than 10% of Chevron’s production, but has investors transfixed.

Johnson & Johnson could become the second biopharma company to achieve $100 billion in annual sales. The healthcare leader has a robust and diversified business that can support its dividend program.

High-quality dividend stocks like OKE, PFE, and CAG gain as low rates and OKE's 5.6% yield drive upside. Find out why SCHD ...

"If you can keep them in the market and then capture enough of the upside over time, you can really help people build wealth ...," the fund manager said.

Chevron Corp. reports mixed Q4 2025 results with revenue missing consensus and earnings beating it. Company achieved synergy ...

Companies on this list have withstood the test of time.

First National Bank Alaska (FBAK) declares $4.00/share quarterly dividend, in line with previous. Forward yield 5.21% Payable ...

The fourth quarter demonstrated weakness across nearly all areas and segments, with the exception of the technology division, ...

Chevron's board has raised the energy giant's quarterly dividend by 4.1%, to $1.78 from $1.71. The new payout, equal to $7.12 a year, represents an annual yield of about 4.16% based on Thursday's ...

Discover three Dividend Kings built for all market conditions. These stocks offer decades of dividend growth, steady revenue, ...

These five top blue-chip stocks underperformed last year and look poised to rebound in 2026. Two are Warren Buffett favorites.